PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2011Science604 citationsOpen Access

Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure

View Full Paper
Fady I. Malik
Fady I. MalikHeart Failure / Cardiomyopathy
JHJames J. HartmanCytokinetics (United States)KEKathleen A. EliasNCR (United States)

Structured PICO

Does a small molecule cardiac myosin activator improve cardiac function in systolic heart failure?

P
Population
Systolic Heart Failure
I
Intervention
Small molecule cardiac myosin activator
O
Outcome
Cardiac functionsurrogate

Cardiac myosin activation via a small molecule represents a potential therapeutic approach to improve cardiac function in systolic heart failure.

Abstract

A small molecule improves cardiac function by accelerating the transition of myosin into a force-producing state.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Malik et al. (2011) studied this question.

synapsesocial.com/papers/6995afcb206d9796cebc4ed9https://doi.org/10.1126/science.1200113
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of Cardiac Myosin Isoform Variation on Myofilament Function and Crossbridge Kinetics in Transgenic Rabbits2009 · 33 citations
  2. 2Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2consumption in dogs2007 · 63 citations
  3. 3NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle2002 · 313 citations
  4. 4Three-dimensional structure of myosin subfragment-1: a molecular motor1993 · 2,078 citations
  5. 5A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs1999 · 17 citations